ARMCX1 inhibits lung adenocarcinoma progression by recruiting FBXW7 for c-Myc degradation
Authors:
Open Access
- 16 September 2024
- journal article
- research article
- Published by Springer Nature in Biology Direct
- Vol. 19 (1) , 82
Abstract
BackgroundArmadillo Repeat Containing X-Linked 1 (ARMCX1), a member of the ARM Repeat X-linked protein family, exerts inhibitory function in various tumors. However, its biological role in lung adenocarcinoma (LUAD) and the underlying molecular mechanisms require further exploration.MethodsLUAD tissue microarrays and bioinformatic databases were used to evaluate the relationship between ARMCX1 and clinicopathological features. The influence of ARMCX1 on LUAD cell proliferation, migration, and invasion in vitro was determined by colony formation, CCK-8, EdU incorporation, cell cycle, wound healing, and Transwell assays. The impact of ARMCX1 on LUAD cell growth and metastasis in vivo was determined by subcutaneously transplanted tumor and pulmonary metastasis assays. Western blot, immunoprecipitation, immunofluorescence, cycloheximide, and proteasome inhibitor assays were finally conducted to explore the potential underlying molecular mechanisms.ResultsARMCX1 expression was downregulated in clinical LUAD samples due to which patient prognoses were poor. Functional experiments indicated that ARMCX1 overexpression inhibited the growth and metastasis of LUAD cells in vitro and in vivo. The molecular mechanism suggested that ARMCX1 recruits the E3 ubiquitin ligase FBXW7 for mediating ubiquitinated degradation of c-Myc, suppressing its nuclear accumulation, and ultimately inactivating cell cycle and epithelial-mesenchymal transition (EMT) signals.ConclusionARMCX1 inhibits LUAD cell proliferation and metastasis by interacting with c-Myc and enhancing its ubiquitination and degradation. Consequently, it can act as a tumor suppressor in this disease. These results suggest that ARMCX1 is a potential target in the treatment of LUAD.Keywords
Funding Information
- Yilin Wu (2024A03J1058)
- Yanli Tong (2023A03J0882)
This publication has 46 references indexed in Scilit:
- Copy number loss of FBXW7 is related to gene expression and poor prognosis in esophageal squamous cell carcinomaInternational Journal of Oncology, 2012
- ALEX1 suppresses colony formation ability of human colorectal carcinoma cell linesCancer Science, 2012
- MYC on the Path to CancerCell, 2012
- Human Arm protein lost in epithelial cancers, on chromosome X 1 ( ALEX1 ) gene is transcriptionally regulated by CREB and Wnt/β‐catenin signalingCancer Science, 2010
- Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: Clinical significanceInternational Journal of Cancer, 2009
- The Armadillo Repeat-containing Protein, ARMCX3, Physically and Functionally Interacts with the Developmental Regulatory Factor Sox10Journal of Biological Chemistry, 2009
- Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and SurvivorshipMayo Clinic Proceedings, 2008
- The c-Myc target gene networkSeminars in Cancer Biology, 2006
- The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradationProceedings of the National Academy of Sciences, 2004
- ALEX1, a Novel Human Armadillo Repeat Protein That Is Expressed Differentially in Normal Tissues and CarcinomasBiochemical and Biophysical Research Communications, 2001